Perceptive Advisors - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 89 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2020$2,156,000
-32.5%
400,0000.0%0.02%
-51.1%
Q3 2020$3,192,000
-20.3%
400,0000.0%0.05%
-27.7%
Q2 2020$4,004,000
+584.4%
400,000
+711.3%
0.06%
+333.3%
Q2 2018$585,00049,3020.02%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders